Treatment of pharmaceutical company’s rebates for VAT purposes; refund opportunities

France’s Supreme Tax Court (“Conseil d’Etat”) held that for value added tax (VAT) purposes, companies can reduce their taxable base to reflect certain “conventional rebates.”

Source

• KPMG
• Deloitte

See also ECJ C-462/16 – Boehringer Ingelheim Pharma GmbH & Co. KG – Judgment – Discounts reduce the VAT value of pharmaceutical supplies